Product Description

The antigens CD33 and CD66 are expressed on bone marrow derived myeloid cells such as myeloid progenitor cells, monocytes/macrophages, and granulocytes (neutrophils, basophils, and eosinophils). These cells play key roles in the adaptive and innate immune responses.

Myeloid cells are obtained by positive selection using antiCD33 and antiCD66 antibodies and immunomagnetic separation techniques from bone marrow mononuclear cells (MNCs). CD33⁺CD66⁺ myeloid cells are characterized by the expression of CD14 and CD66b by flow cytometry.

Cells were obtained using Institutional Review Board (IRB) approved consent forms and protocols.

Format

Catalog #

QTY/Unit

Cryopreserved

BM3366001C

BM3366002C

BM3366005C

1 million/vial

2 million/vial

5 million/vial

Product Specification

Species:	Human
Cell Source:	Bone Marrow
Product Type:	Primary Cells
Cell Type:	Myeloid Cells
Donor Attributes:	HIV-, HepB-, HepC-
Purity:	≥90% by Flow Cytometry
Viability:	≥85% by Flow CytometryNote: For cryopreserved samples the freeze thaw cycle may decrease cell viability by 10-15% post thaw.
Contains:	Fresh: PBS with 5% FBS and 0.5% BSA Frozen: CryoStor™ CS10 (10% DMSO)